GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (STU:TEHN) » Definitions » Debt-to-Revenue

Avid Bioservices (STU:TEHN) Debt-to-Revenue : 1.44 (As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is Avid Bioservices Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Avid Bioservices's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €131.0 Mil. Avid Bioservices's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €47.9 Mil. Avid Bioservices's annualized Revenue for the quarter that ended in Jan. 2024 was €124.2 Mil. Avid Bioservices's annualized Debt-to-Revenue for the quarter that ended in Jan. 2024 was 1.44.


Avid Bioservices Debt-to-Revenue Historical Data

The historical data trend for Avid Bioservices's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Debt-to-Revenue Chart

Avid Bioservices Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.45 1.23 1.53 1.27

Avid Bioservices Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.19 1.19 1.25 1.92 1.44

Competitive Comparison of Avid Bioservices's Debt-to-Revenue

For the Biotechnology subindustry, Avid Bioservices's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avid Bioservices's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's Debt-to-Revenue falls into.



Avid Bioservices Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Avid Bioservices's Debt-to-Revenue for the fiscal year that ended in Apr. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.238 + 171.342) / 136.131
=1.27

Avid Bioservices's annualized Debt-to-Revenue for the quarter that ended in Jan. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(131.027 + 47.892) / 124.168
=1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jan. 2024) Revenue data.


Avid Bioservices Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices (STU:TEHN) Business Description

Traded in Other Exchanges
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Avid Bioservices (STU:TEHN) Headlines

No Headlines